Stream Biomedical
Stream Biomedical Inc. is dedicated to developing first-in-class targeted therapeutics for the treatment of acute neurotrauma and chronic neurodegenerative diseases. They focus on revolutionizing cerebrovascular repair and developing novel solutions for neurotrauma and neurodegeneration, including stroke, traumatic brain injury, and Alzheimer's disease.
Industries
Nr. of Employees
small (1-50)
Stream Biomedical
Products
Perlecan domain V–derived recombinant biologic candidates (including LG3 subdomain constructs)
Research-stage recombinant protein therapeutics derived from perlecan domain V and its LG3 subdomain evaluated for neuroprotection, restoration of angiogenic function, and cerebrovascular repair in preclinical models of stroke, TBI, and Alzheimer-type pathology.
Perlecan domain V–derived recombinant biologic candidates (including LG3 subdomain constructs)
Research-stage recombinant protein therapeutics derived from perlecan domain V and its LG3 subdomain evaluated for neuroprotection, restoration of angiogenic function, and cerebrovascular repair in preclinical models of stroke, TBI, and Alzheimer-type pathology.
Services
Research, preclinical efficacy testing, publication, and clinical-stage development activities for recombinant biologic candidates targeting neurotrauma and neurodegeneration.
Research, preclinical efficacy testing, publication, and clinical-stage development activities for recombinant biologic candidates targeting neurotrauma and neurodegeneration.
Expertise Areas
- Stroke therapeutics and neurovascular repair
- Traumatic brain injury therapeutics
- Alzheimer's disease-related neurovascular protection
- Recombinant biologic therapeutic development
Key Technologies
- Recombinant protein engineering
- Rodent ischemic stroke models
- Rodent traumatic brain injury models
- 3D neurovascular imaging
News & Updates
Event held on March 13th, 2025, related to neurotherapeutics.
A publication on neuroprotective effects in stroke.
An external publication on brain repair after stroke.
Research on cellular mechanisms involving caspase-3.
Study on growth factors and stem cell pathways.
Research on amyloid-beta toxicity and angiogenesis.
Event held on March 13th, 2025, related to neurotherapeutics.
A publication on neuroprotective effects in stroke.
An external publication on brain repair after stroke.
Research on cellular mechanisms involving caspase-3.
Study on growth factors and stem cell pathways.
Research on amyloid-beta toxicity and angiogenesis.